Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02173405 · ClinicalTrials.gov registry record · Phase 1
Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
A Phase 1 study of Trigger Point Pain, Myofascial and Myofascial Trigger Point Pain, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 3
- Study locations
NCT02173405 is a Phase 1 study of Trigger Point Pain, Myofascial and Myofascial Trigger Point Pain that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 10 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT02173405, a Phase 1 study of Trigger Point Pain, Myofascial and Myofascial Trigger Point Pain, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study because is looking at woman with symptoms of chronic pelvic pain caused by short, tight, and tender pelvic floor muscles (Myofascial Pelvic Pain syndrome). The purpose of this study is to determine whether or not injections with onabotulinumtoxinA (Botox) improve symptoms of pain and tenderness. The drug being studied, Botox is FDA approved for other uses. However, Botox is not FDA approved for the use in myofascial pelvic pain (MPP). Therefore, Botox is considered experimental or research in this study.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG OnabotulinumtoxinA
Study Locations (3)
Ohio
- University Case Medical Center - Cleveland
- University Hospitals Landerbrook Health Center, Urology - Mayfield Heights
- University Hospitals Westlake Health Center, Urology - Westlake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-08-01 |
| Est. Completion | 2016-09-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02173405
The ClinicalTrials.gov registry entry for NCT02173405 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Trigger Point Pain, Myofascial appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02173405 reports 3 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02173405 about?
NCT02173405 is a clinical study titled "Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain". This research study because is looking at woman with symptoms of chronic pelvic pain caused by short, tight, and tender pelvic floor muscles (Myofascial Pelvic Pain syndrome). The purpose of this study is to determine whether or not injections with onabotulinumtoxinA (Botox) improve symptoms of pain...
What is the current status of trial NCT02173405?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2014-08-01. Estimated completion is 2016-09-01.
What conditions does trial NCT02173405 study?
This clinical trial studies the following conditions: Trigger Point Pain, Myofascial, Myofascial Trigger Point Pain, Myofascial Pain Syndromes.
What interventions are being tested in trial NCT02173405?
The interventions under investigation include: Placebo (DRUG), OnabotulinumtoxinA (DRUG).
Who is sponsoring clinical trial NCT02173405?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02173405 being conducted?
This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trigger Point Pain, Myofascial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.